Quantcast
Close Window
   
Welcome to 2018 :o)
HomeAbout

Content List
100+ articles of harm and corruption by Johnson & Johnson and subsidiary products.
Click for content list...

 
POSTED APRIL 9, 2018: Without financial support, site goes down on April 26, 2018. I can't do this alone... have not had even one gift of support since February. I am homeless and on the streets, I have NO MONEY for this. I really need some help to keep this six years of work online, PLEASE.
 
THIS WORK FOR SAFE HEALTHCARE PRODUCTS IS BEING DONE BY A 50 YEAR OLD HOMELESS WOMAN, homeless and on the streets since 2011 after loss of my management job and subsequent foreclosure on my house. I grew up in foster care so I have no family and no friends in a position to help me. I REQUIRE ENOUGH MONEY FOR ONLY THREE THINGS:
 
1. Cell phone with internet access. I cannot load files TO the web site from public service connections. This block is required to prevent hackers from using public access connections. I cannot write content and load it to the site until my phone is back on. Phone was shut down on the fourth because I have NO MONEY and almost NO SUPPORT FOR THIS WORK.
 
2. 4 foot by 4 foot storage unit to keep computer, periferals, back-ups and what pathetic little I have left of my life, destroyed by my ex, long story. Storage was locked up by managment on the 9th due to non-payment because I have NO MONEY and almost NO SUPPORT FOR THIS WORK. I have been wearing the same filthy stinking clothes for 10 days now because I have NOTHING LEFT BUT THE CLOTHES ON MY BACK AND A BAG WITH LAPTOP AND SOME TOILETRIES. The bag will likely get stolen in the near-distant future because I have to sleep sometimes and can't keep watch on the bag when I'm sleeping. Already had FIVE laptops stolen because I have to sleep. It was why I got the storage unit in the first place.
 
3. SERVER FEES TO KEEP ALL THIS WORK ONLINE. Obviously, no server space, no site, total end of this effort. I have NO MONEY to pay the server fees that are due on the 26th.
 
Must have to continue: $250
Gifts of support sent
as of 4 PM April 19, 2018: $0
 
NOT ONE PENNEY SINCE FEBRUARY. I stretched the money from January and February to cover January, February and March. I have less than $2 left.
 
Of the 2 million page views this site has received, over 6,000 were from Johnson & Johnson servers. I'm sure they are celabrating my failure to obtaion financial support and look forward to the site going down on the 26th. Crossing their fingers that no one chooses to help.
 
I'm sorry I have no money to pay for the tools REQUIRED to continue this work. I wish I did, I hate the thought of all this work going offline after 6 YEARS of a massive amount of work, 100 hour weeks. But if there's no support, I guess people are okay with the way Johnson & Johnson does business and all this work will be gone in less than a week. I did what I could...
 
Thank you,   
Emily
 
$.00         
 
This is INDEPENDENT, AD-FREE work that you are certainly NOT going to see in conventional media.
 
List of content exposing harm and corruption compiled since March of 2012
 
If you'd like to help keep me writing, tweeting the information to Trump, US Senate, US Attorneys General, State Governors, US government health agencies such as FDA/CDC, etc, useless (fake) media, JNJ shareholders, it would be much appreciated if you would send a gift to help keep this effort going.
 
If money comes in to save the site:
Next planned articles...

FOUR Corporate Defense Attorneys Are In Control of US Health and Human Services
JNJ Shareholders in a Huff Over Talc
Kudos to Trump for Cutting Millions of Poor From Medicaid
Johnson & Johnson Innovative Population Control Strategy
Founder of Apotex and Wife Found Hung in Home Likely Visited JohnsonAndToxin Site Researching ....
(got more dead to report - explain later.)
Johnson & Johnson CEO Gorsky Wants to "CREATE A CRISIS"; gee, looks like he's created quite a few ;o)
 
Thank you,   
Emily
 
$.00         
 
JOHNSON & JOHNSON PARTIAL USA LAWSUIT LIST...
 
Baby powder ovarian cancer lawsuits
Metal-on-metal hip lawsuits
Xarelto DEATH and bleed-out lawsuits
Hernia and transvaginal mesh lawsuits
Invokana ketoacidosis, etc. lawsuits
Deadly, disabling Risperdal lawsuits
Deadly, disabling Levaquin lawsuits
* Velcade overcharging lawsuits
* Procrit heart attack lawsuits
* Stelera cancer lawsuits
* Morcellators uterine cancer lawsuits
* Tylenol death and liver failure lawsuits
* Defective diabetes device lawsuits
* Defective heart stent lawsuits
* Death and disability spine disc lawsuits
* Deadly bone cement lawsuits "Pigs injected with the cement died within minutes"
* Deadly, disabling opioid lawsuits
* Defective knee lawsuits
* Defective elbow lawsuits
* Deadly defective surgical tool lawsuits
* Topamax birth defect and suicide lawsuits
 
* NEW: January 2, 2018, CLASS ONE RECALL of heart device
 
This list is NOT all-inclusive and covers ONLY lawsuits in the United States.
 
* NOT mentioned on 2017 3rd 1/4 10Q

Glad to see you :o)
Notable visitors to the web site include:
 
US GOVERNMENT:
United States Air Force
US Senate
US Department of Defense
US Department of Justice
US Homeland Security
US Centers for Disease Control
 
GLOBAL FINANCIAL INSTITUTIONS:
Vanguard
Barclays
The Bank of New York Mellon Corp
Lloyds Banking Group PLC
Royal Bank of Canada
Bank of America
Harris Trust & Savings Bank
Deutsche Bank
Macquarie Bank
PNC Bank
Crédit Agricole Bank
Royal Bank of Scotland
Raymond James Financial
BlackRock Financial Management
...and many, many more from all over the world ;o)
 
Feel free to browse list of notable visitors to the web site.
 

YET ANOTHER TWITTER ACCOUNT SHUT DOWN! @JNTNews was suspended. New account is @REALITYofJNJ
Johnson & Johnson Janssen Xarelto Marketed In Violation of FDA Regulations
Here we go again - another drug with false and misleading marketing that downplays risks. Gee, another set of lawsuits waiting to happen :o)

Keywords: jnj, johnson and johnson, johnson + johnson, J&J, xarelto, FDA, marketing, violation
Date Created/Edited: July 21, 2013
 

Most Recent Content....
Pharma Company Facing Over 108,000 Lawsuits Awarded $300 Million in Defense Department Contracts
Nothing like the best for United States Veterens, eh?
 
Johnson & Johnson Adds Another Two Thousand Lawsuits in Third Quarter 2017
Lawsuits against Johnson & Johnson continue to spiral out of control - breaking over 108,000 in third quarter 2017, with numerous unmentioned products also racking up an untold number of lawsuits not mentioned in 2017 10-Q.
 
History of Johnson & Johnson Janssen Fentanyl
Hmm, looks like Johnson & Johnson is profiting from BOTH sides of opioid addiction crisis ;o)
 
15 Steps to Solve Healthcare Crisis
How about this for a rough outline of a strategy to dramatically reduce healthcare costs?
 
ACA the Affordable CORRUPTION Act
The only purpose of the ACA/ObamaCare was to force everyone to pay legal fees and victim settlements and care from harm by Johnson & Johnson.
 
Johnson & Johnson Begs US FDA to Expand Xarelto Slaughter
After killing around 2,000 people in the United States in 2016 alone, Johnson & Johnson wants to spread the deaths even more!
 
Johnson & Johnson Facing Over $100 BILLION in Lawsuit Debt
With a flood of lawsuits pouring in from around the world, Johnson & Johnson is facing at least $100 BILLION lawsuit debt.
 
The Johnson & Johnson Drugged Kids Pension Plan
Teacher and state retirement funds invest in Johnson & Johnson, the DRUGGED KIDS PENSION PLAN
 
Second Quarter 2017 Lawsuits Against Johnson & Johnson
Lawsuits against Johnson & Johnson in United States holding at 106,600! DOES NOT INCLUDE ALL PRODUCTS FACING LAWSUITS OR LAWUITS FILED OUTSIDE THE UNITED STATES!
 
Special Sections....
Mesh Files
Baby Powder (talc) Files
Risperdal Files
Levaquin Files
Xarelto Files
Hips Files
Letters to Shareholders
SEC Lawsuits Files

 
Recent Content....
Why President Trump Should Shut Down US FDA (2017, March 28)
Healthcare organizations around the world depend on US FDA decisions, however, profit, rather than safety, seems to be the primary motivation.
healthcare, health, obamacare, donald, trump, fda, fraud, kickback
 
The Difference Between Guinea Pig and Cash Cow (2016, September 27)
People keep saying pharma is using us as 'guinea pigs'. Uh, not quite. Take a minute to learn the difference between a 'guinea pig' and a 'cash cow'.
guinea pig, immunization, vaccination, profit, harm, autism, disability, asthma
 
Johnson & Johnson Victims at Risk of RE-Victimization (2016, August 22)
If you are currently a victim of a known harmful Johnson & Johnson subsidiary product and have high medical needs due to your injuries, you are at increased risk of becoming a victim of another known harmful Johnson & Johnson subsidiary product.
jnj, johnson and johnson, johnson & johnson, victim, mesh, hip, levaquin, risperdal
 
Johnson & Johnson Animas Defective Diabetes Devices (2016, August 4)
Gosh and golly gee willikers, yet another Johnson & Johnson subsidiary, Animas, totally sucks, jah?
Johnson and Johnson, Johnson & Johnson, animas, vibe, diabetes, insulin, device, pump
 
Johnson & Johnson Ethicrap, I Mean EthiCON, More JNJ JUNK (2016, July 25)
As I've mentioned, Johnson & Johnson has so many bad products I have to put a bunch in each article now to try to keep up. Now for EthiCON crap.
Johnson and Johnson, Johnson & Johnson, ethicon, harmonic ace, morcellator, physiomesh, secure strap, stapler
 
Gee, here we go again. Xarelto is a Johnson & Johnson drug approved for certain conditions by the FDA since introduced in 2011. On June 6, 2013, the United States Food and Drug Administration (USFDA) sent Johnson & Johnson a warning letter for false advertising. In the FDA letter to Johnson & Johnson states, "The print ad is false or misleading because it minimizes the risks associated with Xarelto and makes a misleading claim."
 
This was also the case withLevaquin, Risperdal and even Exelon - all with FDA violations of false or misleading claims in their advertising material and all under the direct control of current CEO Alex Gorsky. Our doctors are literally being lied to regarding the safety and effectiveness of J&J pharmaceutical products and medical devices. How do you think that might affect your physician's choices for your treatment?
 
If you look at the information from the first article I wrote on Xarelto, you'll realize that if a doctor knew the truth they'd never prescribe the drug. For example, Xarelto is not proven to effectively treat the conditions for which it is prescribed. Xarelto costs more than known effective and currently available drugs. Xarelto has more side effects than currently available, proven-effective drugs. So basically, the insert should state that it is not proven, is more expensive and has more side effects. Yeah, I can see docs rushing to prescribe this based on the truth.
 
But then again, this is another drug slammed though a corrupt USFDA by The King of Corruption, JNJ Alex Gorsky. Xarelto is another drug brought to you by a corporation, Johnson & Johnson that used Freedom of Speech, or a Constitutional right to lie, as a defense with regard to the Arkansas verdict of $1.2 BILLION in restitution for Risperdal.
 
I wonder, if Johnson & Johnson products are so great, why do they have to lie about them to sell them? Would they be able to sell their products if they told the truth? With yet another product that safety data was not submitted to the FDA, less effective than existing products, more expensive than existing products and has more side effects than existing products, well, I doubt it.
 

Original Article, "Xarelto by Johnson & Johnson is Likely Another OverHyped Dud"
UPDATE: MAY 24, 2012
The FDA showed intelligence for a change and did not approve Xarelto for expanded use explaining that Agency advisers say there's not enough data in company trials on benefit for high-risk patients. The article contains additional information regarding the missing data of the outcome of a 15,000 patient clinical study. One of the FDA reviewers suggested that the missing data may indicate that Xarelto is not effective as J&J claims for expanded use in treating acute coronary syndrome.
 
Original article:
Here we go again - another supposed blockbuster drug with issues but will get pushed through FDA anyway. Xarelto is a blood thinner used during major surgeries to reduce the risks of blood clots. It is now being pushed through FDA for regular use to reduce the risk of blood clots in people with acute coronary syndrome. However, due to missing data, "The staff appeared united in the view that the data did not prove Xarelto reduced the risk of death in patients with acute coronary syndrome..." according to Reuters.
 
In the same article, it is clearly stated that 12% of those in clinical trials dropped out. ANNNND - there were three deaths while on the drug that were excluded from information submitted to the FDA. Gee, what's this? If the people in the clinical trial DIE from the drug, they don't count? OMG. No wonder there are so many lawsuits against J&J!
 
According to the available FDA information, Xarelto was not demonstrated to be more effective than currently available drugs - but has more side effects as well as a higher cost. And we all know what more side effects means, they can sell more drugs to deal with the side effects.
 
Missing data, 12% dropout rate (or lost track of) and three deaths should be a sure sign that J&J knows there are issues with the drug. In addition, the expectation of such a large number of recipients to total over a billion in sales, although the drug should not be prescribed to those under 18, over 65, anyone with high blood pressure, etc, as well as the known and published side effects - um, how, exactly, could this be a 'blockbuster'? What I see is more off-label marketing to meet the sales goals and more harm with the resulting lawsuits. Oh, joy. Higher health care costs to pay for yet another 'blockbuster'. More like 'economy buster'.
 
Resources:
1. Zarna Patel and Amy Toscano (2013, June 6). FDA WARNING LETTER. Office of Prescription Drug Promotion, United States Food and Drug Administration. Retrieved from http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM357833.pdf
 
2. Emily Patterson (2013, May 8). List of Reasons Johnson & Johnson CEO Alex Gorsky Should Immediately Resign. Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/alex_gorsky_resignation.shtml
 
3. Emily Patterson (2012, November 9). Johnson & Johnson CEO Alex Gorsky's Career Long Cloud of Corruption. Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/alex_gorsky_corruption.shtml
 
4. Emily Patterson (2013, June 20). Johnson & Johnson Defense Against $1.2 Billion Arkansas Risperdal: We Have a Constitutional Right to Lie. Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/right_to_lie.shtml
 
5. Emily Patterson (2012, April 13). Johnson & Johnson Risperdal: Broken Laws and Side Effects. Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/risperdal.shtml
 
6. Emily Patterson (2012, May 23). Xarelto by Johnson & Johnson is Likely Another OverHyped Dud. Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/xarelto.shtml
 
7. HealthDay Correspondent (2012, May 23). FDA Panel Votes Against New Use for Blood Thinner Xarelto. US News and World Report. Retrieved from http://health.usnews.com/health-news/news/articles/2012/05/24/fda-panel-votes-against-new-use-for-blood-thinner-xarelto
 
8. Anna Yukhananov (2012, May 21). FDA staff sends mixed message on J&J drug Xarelto. Reuters. Retrieved from http://www.reuters.com/article/2012/05/21/us-fda-johnson-xarelto-idUSBRE84K0M220120521?feedType=RSS&feedName=healthNews&utm_source=twitterfeed&utm_medium=twitter&utm_campaign=Feed%3A+reuters%2FhealthNews+%28Reuters+Health+News%29
 
All contents Copyright © 2012-2017 Emily Patterson / Johnson and Toxin. All rights reserved.
 
Web Site and Admin Info:
Home
About
Contact
Disclaimers
Privacy Policy
Site Statistics
Site Resources
Financial Disclosure

 
Recently Posted:
2015 Johnson & Johnson US Lawsuit Update: Jump from 48,500 to 56.500
 
Johnson & Johnson Plans to Expand Healthcare Cost Crisis and Product Liability in Asia
 
Who REALLY Pays for Drug Development? US TAXPAYERS - $21 BILLION for fiscal year 2014
 
Johnson & Johnson Janssen Xarelto Marketed In Violation of FDA Regulations
 
Johnson & Johnson Destroys Thousands of Files Related to Vaginal Mesh
 
Johnson & Johnson: The Global Lawsuit Company


 
 
Most Popular:
The Ever-Growing Number of Lawsuits Against Johnson & Johnson
 
Johnson & Johnson Credo Analysis
 
Johnson & Johnson $4 Billion for DePuy Hip Harm in U.S., With Lawsuits in at Least 4 More Countries